17β-Estradiol Vaginal Tablet Versus Conjugated Equine Estrogen Vaginal Cream to Relieve Menopausal Atrophic Vaginitis

Rioux, Jacques E.; Devlin, Corinne M.; Gelfand, Morrie M.; Steinberg, Wilfred M.; Hepburn, D. S.

doi:10.1097/00042192-200007030-00005

Cited by 179 publications

(131 citation statements)

References 0 publications

Supporting

Mentioning

123

Contrasting

Unclassified

Order By: Relevance

“…This is supported by Lo et al who showed postmenopausal status is independent predictors for de novo SUI following extensive POP repair (19). In addition, estrogen replacement is thought to alleviate incontinence by facilitating proliferation and maturation of urethral mucosa in postmenopausal women (24). Our study also found the risk of OSUI was increased in postmenopausal women and decreased with hormone replacement therapy.…”

Section: Discussionsupporting

confidence: 85%

The Prevalence and Risk Factors of Occult Stress Urinary Incontinence in Women Undergoing Genitourinary Prolapse Surgery

Latip¹

2016

JSA

View full text Add to dashboard Cite

De novo stress urinary incontinence (SUI) may occur in up to 80% of clinically continent women following genitourinary prolapse surgery. This had resulted in an increase in the rate of concurrent continence surgery during prolapse repair from 38% in 2001 to 47% in 2009 in the United States. To date, there is no local data available to estimate the prevalence of occult SUI (OSUI) among Malaysian women awaiting surgery. Therefore, this study was conducted to elicit the prevalence of occult SUI and its associated risks factors in patients awaiting prolapse surgery. We retrospectively studied the records of 296 consecutive women with significant pelvic organ prolapse awaiting reconstructive repair. All patients attended the Urogynaecology Unit in Hospital Kuala Lumpur Malaysia between October 2007 and September 2011. They had undergone standardized interviews, clinical examinations and urodynamic studies. During the urodynamic testings, all prolapses were reduced using ring pessaries to elicit OSUI. Primary outcome was the prevalence of OSUI with prolapse reduction to predict possibility of developing de novo SUI following prolapse surgery. Secondary outcome was the assessment of potential risk factors for OSUI. Among the 296 women studied, 121 (40.9%) were found to have OSUI. The risk factors associated with OSUI included age, BMI, numbers of SVD, recurrent UTI, reduction of urinary flow symptoms and grade 2 to 4 central compartment prolapses. We concluded that preoperative urodynamic testing with reduction of prolapse is useful to identify women with OSUI. This is important for preoperative counselling as well as planning for one step approach of prophylactic concomitant anti-incontinence procedures during prolapse surgery in order to avoid postoperative de novo SUI.

show abstract

Section: Discussionsupporting

confidence: 85%

The Prevalence and Risk Factors of Occult Stress Urinary Incontinence in Women Undergoing Genitourinary Prolapse Surgery

Latip¹

2016

JSA

View full text Add to dashboard Cite

show abstract

“…The questionnaire was adapted from previous studies of estrogen therapy for vaginal atrophy [25][26][27]. The patient was asked to rate the severity of "dryness of the vagina," "itching or irritation of the vagina or vulva," and "pain with intercourse" on a four-point scale (0, none; 1, mild; 2, moderate; 3, severe).…”

Section: Measurementsmentioning

confidence: 99%

Topical Testosterone for Breast Cancer Patients with Vaginal Atrophy Related to Aromatase Inhibitors: A Phase I/II Study

et al. 2011

View full text Add to dashboard Cite

After completing this course, the reader will be able to:1. Evaluate early data regarding the impact of daily vaginal testosterone on estradiol and testosterone levels in breast cancer patients receiving treatment with aromatase inhibitors.2. Explain the potential clinical benefits of vaginal testosterone therapy to treat vaginal atrophy in women with breast cancer receiving long-term aromatase inhibitor therapy.This article is available for continuing medical education credit at CME.TheOncologist.com. CME CME The Oncologist CME Program is located online at http://cme.theoncologist.com/. To take the CME activity related to this article, you must be a registered user. ABSTRACT Breast CancerThe

show abstract

“…Patients have reported that the tablets are easier to use and less messy than cream preparations and are technically easier to insert than estrogen rings [40]. …”

Section: A Typical Multimodal Therapeutic Management Schemementioning

confidence: 99%

Sexual Oncology: Sexual Health Issues in Women with Cancer

Krychman¹,

Pereira

Carter³

et al. 2006

Oncology

View full text Add to dashboard Cite

Sexual problems are widespread among female cancer patients and survivors. Dysfunction may result from various oncologic therapies such as surgery, radiation therapy, chemotherapy, hormonal manipulation, and cytostatic medication. Additionally, psychologic distress that the patient or her partner experiences during diagnosis and treatment of malignancy can impair a healthy female sexual response cycle. A sexual rehabilitation program in an oncology setting is necessary to provide comprehensive care to the cancer patient and her partner. A multidisciplinary treatment approach to sexual dysfunction includes psychological and psychiatric intervention, medical intervention, cognitive behavioral therapy, and recommended lifestyle adjustments. A holistic approach to assessing and treating sexual concerns should be individually tailored to the female patient in light of her disease stage and prognosis, age, marital status, fertility concerns, and social and professional environment.

show abstract

17β-Estradiol Vaginal Tablet Versus Conjugated Equine Estrogen Vaginal Cream to Relieve Menopausal Atrophic Vaginitis

Cited by 179 publications

References 0 publications

The Prevalence and Risk Factors of Occult Stress Urinary Incontinence in Women Undergoing Genitourinary Prolapse Surgery

The Prevalence and Risk Factors of Occult Stress Urinary Incontinence in Women Undergoing Genitourinary Prolapse Surgery

Topical Testosterone for Breast Cancer Patients with Vaginal Atrophy Related to Aromatase Inhibitors: A Phase I/II Study

Sexual Oncology: Sexual Health Issues in Women with Cancer

Contact Info

Product

Resources

About